Corpus Intelligence IC Memo — SSM HEALTH ST. MARYS HOSPITAL - STL 2026-04-26 12:47 UTC
IC Memo — SSM HEALTH ST. MARYS HOSPITAL - STL
Investment Committee Memorandum | MO | 501 beds | Grade C | EBITDA uplift $58.4M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

SSM HEALTH ST. MARYS HOSPITAL - STL

CCN 260091 | ST. LOUIS, MO | 501 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

SSM HEALTH ST. MARYS HOSPITAL - STL is a 501-bed suburban community hospital in ST. LOUIS, MO with $792.8M in net patient revenue and a -0.0% operating margin. The hospital serves a payer mix of 10.8% Medicare, 10.8% Medicaid, and 78.4% commercial.

Thesis: Undervalued. Our ML models identify $58.4M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -0.0% to 7.3% (+736bps).

Net Revenue HCRIS$792.8M
Current EBITDA COMPUTED$-146K
Operating Margin COMPUTED-0.0%
Occupancy HCRIS66.2%
Revenue / Bed COMPUTED$1.6M
Net-to-Gross HCRIS35.6%
Distress Probability ML46.7%

2. Market Context & Competitive Position

138
MO Hospitals
-6.2%
State Median Margin
25
Comparable Hospitals

MO has 138 Medicare-certified hospitals with a median operating margin of -6.2%. The target's margin of -0.0% places it above the state median. Among 25 size-comparable peers (250-1002 beds), the median margin is -2.0%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (250-1002), prioritizing same-state peers. 25 hospitals in the comp set.

HospitalStateBedsRevenueMargin
SSM HEALTH ST. MARYS HOSPITAL (Target)MO501$792.8M-0.0%
CHILDRENS MERCY HOSPITALMO328$1.44B30.5%
MERCY HOSPITAL - ST. LOUISMO815$1.39B13.5%
COXHEALTHMO791$1.38B-7.6%
UNIV OF MISSOURI HEALTH CAREMO521$1.36B-2.0%
MERCY HOSPITAL SPRINGFIELDMO617$1.05B6.1%
ST. LOUIS CHILDRENS HOSPITALMO445$886.1M6.4%
SAINT LUKES HOSPITAL OF KANSASMO466$883.5M-12.4%
SSM SAINT LOUIS UNIVERSITY HOSMO317$772.2M-6.4%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $58.4M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$16.6M+210bp18mo
Cost to Collect4.5%2.5%$15.9M+200bp12mo
Denial Rate Reduction12.0%6.5%$15.7M+198bp12mo
A/R Days Reduction5200.0%3800.0%$9.6M+122bp9mo
Clean Claim Rate88.0%96.0%$507K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$16.6M
Cost to Collect
$15.9M
Denial Rate Reduction
$15.7M
A/R Days Reduction
$9.6M
Clean Claim Rate
$507K
Total EBITDA Uplift$58.4M
Current EBITDA$-146K
+ RCM Uplift+$58.4M
Pro Forma EBITDA$58.2M
Current Margin-0.0%
Pro Forma Margin7.3%
WC Released (1x)$30.4M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-225K$582.6M0.00x-100.0%
Base (11x exit)10.0x11.0x$-225K$640.8M0.00x-100.0%
Bull Case9.0x11.0x$-202K$833.3M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-202K$909.0M0.00x-100.0%
Bear Case11.0x10.0x$-247K$290.9M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-247K$319.9M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 25 hospitals with 250-1002 beds
  • Same-state prioritization (n=26)
  • Comp margins: P25=-11.8% / P50=-2.0% / P75=6.1%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.